Pharmacovigilance Market Report 2026
Download Free Sample Buy Now
Pharmacovigilance Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Pharmacovigilance Market Report 2026

Global Outlook – By Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), By Service Provider (In-House, Contract Outsourcing), By Process Flow (Case Data Management, Signal Detection, Risk Management System), By Clinical Trial Phases (Preclinical, Phase I, Phase II, Phase III, Phase IV), By End User (Hospitals, Pharmaceutical Companies, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Pharmacovigilance Market Overview

• Pharmacovigilance market size has reached to $9.64 billion in 2025

• Expected to grow to $17.41 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%

• Growth Driver: Research And Development Drive Growth In The Pharmacovigilance Market

• Market Trend: Pharmacovigilance Market Embraces Artificial Intelligence For Enhanced Efficiency And Safety

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pharmacovigilance Market?

Pharmacovigilance refers to the science and practices involved in the identification, evaluation, comprehension, and mitigation of side effects and other medical/vaccination-related issues. It is used to determine whether a drug's advantages outweigh its hazards, and it doesn't end once the drugs are approved.

The main types of pharmacovigilance are spontaneous reporting, intensified ADR reporting, targeted spontaneous reporting, cohort event monitoring, and EHR mining. Spontaneous reporting is by nature a passive approach to pharmacovigilance, relying entirely on the motivation of individuals to report suspected adverse drug reactions to local or national pharmacovigilance centers. The different process flows include case data management, signal detection, and risk management systems. The various service providers are in-house and contract to outsource and involve several clinical trial phases such as preclinical, phase I, phase II, phase II, and phase IV. These services are used by several end-users, including hospitals, pharmaceutical companies, and others.

Pharmacovigilance Market Global Report 2026 Market Report bar graph

What Is The Pharmacovigilance Market Size and Share 2026?

The pharmacovigilance market size has grown rapidly in recent years. It will grow from $9.64 billion in 2025 to $10.86 billion in 2026 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increasing adverse drug reaction reporting, expansion of global pharmaceutical approvals, rising clinical trial volumes, establishment of international drug safety regulations, growth in chronic disease drug usage.

What Is The Pharmacovigilance Market Growth Forecast?

The pharmacovigilance market size is expected to see rapid growth in the next few years. It will grow to $17.41 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to real-world data utilization growth, rising biologics and biosimilars approvals, increasing complexity of combination therapies, expansion of pharmacovigilance in emerging markets, growing focus on patient safety outcomes. Major trends in the forecast period include expansion of post-marketing surveillance activities, growing adoption of real-world evidence in safety monitoring, increasing regulatory scrutiny and compliance requirements, rising outsourcing of pharmacovigilance services, integration of multisource safety data platforms.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Pharmacovigilance Market Segmentation

1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining

2) By Service Provider: In-House, Contract Outsourcing

3) By Process Flow: Case Data Management, Signal Detection, Risk Management System

4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV

5) By End User: Hospitals, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals

2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies

3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs

4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies

5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

What Is The Driver Of The Pharmacovigilance Market?

The increasing research and development activities will drive the pharmacovigilance market. By investing in R&D, pharmaceutical companies can develop new and innovative drugs with improved safety profiles. Rigorous preclinical and clinical testing during the drug development process enables early identification of potential safety concerns, allowing for appropriate risk mitigation strategies to be implemented. Additionally, R&D efforts contribute to the advancement of technologies for adverse event monitoring, data analysis, and signal detection, facilitating the early detection of adverse drug reactions in the post-marketing phase. For instance, in 2023, according to Office for National Statistics, a UK-based, government agency, the UK government’s net spending on research and development (R&D) increased to £17.4 billion in 2023, up from £16.1 billion in 2022, marking an 8.2% rise. Therefore, the increasing research and development activities supported the growth of the pharmacovigilance industry.

Key Players In The Global Pharmacovigilance Market

Major companies operating in the pharmacovigilance market are IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation, United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Secure AI Labs, OmniSol dot Tech, Prevnos Inc., Lifescient Inc, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., Novasyte, Fortrea Holdings Inc., Syneos Health Clinical, Telerx Marketing Inc.

Global Pharmacovigilance Market Trends and Insights

Major Companies in the pharmacovigilance market are focusing on artificial intelligence (AI) to improve efficiency. AI can help improve the efficiency and accuracy of pharmacovigilance activities, ultimately leading to better patient outcomes. By utilizing AI, pharma companies can streamline their processes, improve data management, and accelerate drug discovery, while simultaneously reducing costs and improving safety. For instance, in August 2024, the Government of India launched the Adverse Drug Reaction Monitoring System (ADRMS) software, introduced by the Minister of Health & Family Welfare and Minister of Chemicals and Fertilizers. This pharmacovigilance software facilitates the collection and analysis of adverse events related to medicines and medical devices, making the reporting process easier for both consumers and healthcare professionals. This initiative significantly strengthens India's pharmacovigilance infrastructure by ensuring a more comprehensive capture of safety data and enhancing drug safety monitoring. The ADRMS aims to improve the efficiency of drug safety oversight and compliance with standards, helping position India as a leader in the global pharmaceutical industry.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Pharmacovigilance Market?

In January 2023, AmerisourceBergen, an American drug wholesale company, acquired Pharma Lex for an undisclosed amount. This acquisition is expected to add capabilities to the company's existing service offering, allowing the company to provide pharmaceutical and biotech companies with enhanced support and value across the product lifecycle. Pharma Lex’s Germany-based team provides true end-to-end solutions for pharmacovigilance systems and operations, as well as benefit-risk management services.

Regional Insights

North America was the largest region in the pharmacovigilance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharmacovigilance Market?

The pharmacovigilance market includes revenues earned by collecting, analyzing, monitoring, and preventing adverse effects in drugs and therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmacovigilance Market Report 2026?

The pharmacovigilance market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacovigilance industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Pharmacovigilance Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $10.86 billion
Revenue Forecast In 2035 $17.41 billion
Growth Rate CAGR of 12.7% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Service Provider, Process Flow, Clinical Trial Phases, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation, United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Secure AI Lab
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Pharmacovigilance Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Pharmacovigilance Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Pharmacovigilance Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Pharmacovigilance Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Biotechnology, Genomics & Precision Medicine

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Expansion Of Post-Marketing Surveillance Activities

4.2.2 Growing Adoption Of Real-World Evidence In Safety Monitoring

4.2.3 Increasing Regulatory Scrutiny And Compliance Requirements

4.2.4 Rising Outsourcing Of Pharmacovigilance Services

4.2.5 Integration Of Multisource Safety Data Platforms

5. Pharmacovigilance Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies

5.2 Hospitals

5.3 Biotechnology Companies

5.4 Contract Research Organizations

5.5 Academic And Research Institutes

6. Pharmacovigilance Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmacovigilance Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Pharmacovigilance PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Pharmacovigilance Market Size, Comparisons And Growth Rate Analysis

7.3. Global Pharmacovigilance Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Pharmacovigilance Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmacovigilance Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmacovigilance Market Segmentation

9.1. Global Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining

9.2. Global Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

In-House, Contract Outsourcing

9.3. Global Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Case Data Management, Signal Detection, Risk Management System

9.4. Global Pharmacovigilance Market, Segmentation By Clinical Trial Phases, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Preclinical, Phase I, Phase II, Phase III, Phase IV

9.5. Global Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Pharmaceutical Companies, Other End Users

9.6. Global Pharmacovigilance Market, Sub-Segmentation Of Spontaneous Reporting, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals

9.7. Global Pharmacovigilance Market, Sub-Segmentation Of Intensified ADR Reporting, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies

9.8. Global Pharmacovigilance Market, Sub-Segmentation Of Targeted Spontaneous Reporting, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs

9.9. Global Pharmacovigilance Market, Sub-Segmentation Of Cohort Event Monitoring, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies

9.10. Global Pharmacovigilance Market, Sub-Segmentation Of EHR Mining, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

10. Pharmacovigilance Market Regional And Country Analysis

10.1. Global Pharmacovigilance Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Pharmacovigilance Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmacovigilance Market

11.1. Asia-Pacific Pharmacovigilance Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmacovigilance Market

12.1. China Pharmacovigilance Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmacovigilance Market

13.1. India Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmacovigilance Market

14.1. Japan Pharmacovigilance Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmacovigilance Market

15.1. Australia Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmacovigilance Market

16.1. Indonesia Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmacovigilance Market

17.1. South Korea Pharmacovigilance Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmacovigilance Market

18.1. Taiwan Pharmacovigilance Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmacovigilance Market

19.1. South East Asia Pharmacovigilance Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmacovigilance Market

20.1. Western Europe Pharmacovigilance Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmacovigilance Market

21.1. UK Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmacovigilance Market

22.1. Germany Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmacovigilance Market

23.1. France Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmacovigilance Market

24.1. Italy Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmacovigilance Market

25.1. Spain Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmacovigilance Market

26.1. Eastern Europe Pharmacovigilance Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmacovigilance Market

27.1. Russia Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmacovigilance Market

28.1. North America Pharmacovigilance Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmacovigilance Market

29.1. USA Pharmacovigilance Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmacovigilance Market

30.1. Canada Pharmacovigilance Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmacovigilance Market

31.1. South America Pharmacovigilance Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmacovigilance Market

32.1. Brazil Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmacovigilance Market

33.1. Middle East Pharmacovigilance Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmacovigilance Market

34.1. Africa Pharmacovigilance Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmacovigilance Market Regulatory and Investment Landscape

36. Pharmacovigilance Market Competitive Landscape And Company Profiles

36.1. Pharmacovigilance Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Pharmacovigilance Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Pharmacovigilance Market Company Profiles

36.3.1. IQVIA Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Cognizant Overview, Products and Services, Strategy and Financial Analysis

36.3.3. ICON Plc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Accenture plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. PAREXEL International Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Pharmacovigilance Market Other Major And Innovative Companies

United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Secure AI Labs, OmniSol dot Tech, Prevnos Inc., Lifescient Inc

38. Global Pharmacovigilance Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmacovigilance Market

40. Pharmacovigilance Market High Potential Countries, Segments and Strategies

40.1 Pharmacovigilance Market In 2030 - Countries Offering Most New Opportunities

40.2 Pharmacovigilance Market In 2030 - Segments Offering Most New Opportunities

40.3 Pharmacovigilance Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Pharmacovigilance Market, Overview Of Key Products - Product Examples
  • Table 2: Global Pharmacovigilance Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Pharmacovigilance Market, Supply Chain Analysis
  • Table 4: Global Pharmacovigilance Market, Major Raw Material Providers
  • Table 5: Global Pharmacovigilance Market, Major Resource Providers
  • Table 6: Global Pharmacovigilance Market, Major Manufacturers (Suppliers)
  • Table 7: Global Pharmacovigilance Market, Major Distributors And Channel Partners
  • Table 8: Global Pharmacovigilance Market, Key Technologies & Future Trends
  • Table 9: Global Pharmacovigilance Market, Major Trends
  • Table 10: Global Pharmacovigilance Market, Major End Users
  • Table 11: Global Pharmacovigilance Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Pharmacovigilance Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Pharmacovigilance Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Pharmacovigilance Market - TAM, US$ Billion, 2025
  • Table 15: Global Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Pharmacovigilance Market, Segmentation By Clinical Trial Phases, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Pharmacovigilance Market, Sub-Segmentation Of Spontaneous Reporting, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Pharmacovigilance Market, Sub-Segmentation Of Intensified ADR Reporting, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Pharmacovigilance Market, Sub-Segmentation Of Targeted Spontaneous Reporting, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Pharmacovigilance Market, Sub-Segmentation Of Cohort Event Monitoring, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Pharmacovigilance Market, Sub-Segmentation Of EHR Mining, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Pharmacovigilance Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Pharmacovigilance Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Global Pharmacovigilance Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 100: Global Pharmacovigilance Market - Company Scoring Matrix
  • Table 101: IQVIA Financial Performance
  • Table 102: Cognizant Financial Performance
  • Table 103: ICON Plc Financial Performance
  • Table 104: Accenture plc Financial Performance
  • Table 105: PAREXEL International Corporation Financial Performance
  • Table 106: Global Pharmacovigilance Market, Competitive Benchmarking (In USD Billions)
  • Table 107: Global Pharmacovigilance Market, Competitive Dashboard
  • Table 108: Global Pharmacovigilance Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 109: Global, Pharmacovigilance Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 110: Global, Pharmacovigilance Market Size Gain ($ Billion), Segmentation By Service Provider, 2025 – 2030
  • Table 111: Global, Pharmacovigilance Market Size Gain ($ Billion), Segmentation By Process Flow, 2025 – 2030

List Of Figures

    Figure 1: Global Pharmacovigilance Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Pharmacovigilance Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Pharmacovigilance Market, Supply Chain Analysis
  • Figure 4: Global Pharmacovigilance Market, Major Raw Material Providers
  • Figure 5: Global Pharmacovigilance Market, Major Resource Providers
  • Figure 6: Global Pharmacovigilance Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Pharmacovigilance Market, Major Distributors And Channel Partners
  • Figure 8: Global Pharmacovigilance Market, Key Technologies & Future Trends
  • Figure 9: Global Pharmacovigilance Market, Major Trends
  • Figure 10: Global Pharmacovigilance Market, Major End Users
  • Figure 11: Global Pharmacovigilance Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Pharmacovigilance Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Pharmacovigilance Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Pharmacovigilance Market - TAM, US$ Billion, 2025
  • Figure 15: Global Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Pharmacovigilance Market, Segmentation By Clinical Trial Phases, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Pharmacovigilance Market, Sub-Segmentation Of Spontaneous Reporting, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Pharmacovigilance Market, Sub-Segmentation Of Intensified ADR Reporting, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Pharmacovigilance Market, Sub-Segmentation Of Targeted Spontaneous Reporting, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Pharmacovigilance Market, Sub-Segmentation Of Cohort Event Monitoring, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Pharmacovigilance Market, Sub-Segmentation Of EHR Mining, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Pharmacovigilance Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Pharmacovigilance Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Global Pharmacovigilance Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 100: Global Pharmacovigilance Market - Company Scoring Matrix
  • Figure 101: IQVIA Financial Performance
  • Figure 102: Cognizant Financial Performance
  • Figure 103: ICON Plc Financial Performance
  • Figure 104: Accenture plc Financial Performance
  • Figure 105: PAREXEL International Corporation Financial Performance
  • Figure 106: Global Pharmacovigilance Market, Competitive Benchmarking (In USD Billions)
  • Figure 107: Global Pharmacovigilance Market, Competitive Dashboard
  • Figure 108: Global Pharmacovigilance Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 109: Global, Pharmacovigilance Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 110: Global, Pharmacovigilance Market Size Gain ($ Billion), Segmentation By Service Provider, 2025 – 2030
  • Figure 111: Global, Pharmacovigilance Market Size Gain ($ Billion), Segmentation By Process Flow, 2025 – 2030

Industry Forecast: Plasma Fractionation Market to Generate $50.54 Billion Revenue by 2029

Read More About Industry Forecast: Plasma Fractionation Market to Generate $50.54 Billion Revenue by 2029

CAGR of 11.4% Projected for Protein Purification and Isolation Market From 2025 to 2029

Read More About CAGR of 11.4% Projected for Protein Purification and Isolation Market From 2025 to 2029

Emerging Trends and Growth Drivers in the Pulmonary Arterial Hypertension Market Through 2029

Read More About Emerging Trends and Growth Drivers in the Pulmonary Arterial Hypertension Market Through 2029

Latest Market Developments in Specialty Generics Industry: Forecast 2025–2029

Read More About Latest Market Developments in Specialty Generics Industry: Forecast 2025–2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Pharmacovigilance Market Report 2026 - Global Outlook – By Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), By Service Provider (In-House, Cont...

Medical Devices Vigilance Market Report 2026 - Global Outlook – By Delivery Mode (On-Demand, On-Premise), By Application (Therapeutics, Diagnostics, Surgical, Research, Other Applications), By End-User (Original Equipmen...

Cosmetovigilance Market Report 2026 - Global Outlook – By Service Type (Pre-Marketing Services, Post-Marketing Services), By Reported Category (Skincare, Makeup, Haircare, Perfumes And Deodorants, Hair Colorants, Other R...

Therapeutic Drug Monitoring Market Report 2026 - Global Outlook – By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography And Detectors), By Class Of Drug (Antiepileptic Drugs, Antibiotic Drugs, Immunos...

Personal Development Market Report 2026 - Global Outlook – By Instruments (E-Platform, Workshops And Seminars, Books, Personal Training And Coaching), By Focus Area (Mental Health, Motivation And Inspiration, Physical He...

Drug Screening Market Report 2026 - Global Outlook – By Products (Rapid Testing Devices, Consumables, Other Products), By Sample Type (Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types), By ...

Narcotic Drugs Market Report 2026 - Global Outlook – By Drug (Opium, Heroin, Codeine, Oxycodone, Other Drugs), By Source (Natural, Semi-Synthetic, Synthetic), By Indication (Pain Management, Cough, Diarrhea, Dysentery, O...

Pharmaceuticals Market - By Type (Pharmaceutical Drugs, Biologics), By Type Of Pharmaceutical Drugs (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective...

Frequently Asked Questions

The Pharmacovigilance market was valued at $9.64 billion in 2025, increased to $10.86 billion in 2026, and is projected to reach $17.41 billion by 2030.

The global Pharmacovigilance market is expected to grow at a CAGR of 12.5% from 2026 to 2035 to reach $17.41 billion by 2035.

Some Key Players in the Pharmacovigilance market Include, IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation, United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Secure AI Labs, OmniSol dot Tech, Prevnos Inc., Lifescient Inc, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., Novasyte, Fortrea Holdings Inc., Syneos Health Clinical, Telerx Marketing Inc. .

Major trend in this market includes: Pharmacovigilance Market Embraces Artificial Intelligence For Enhanced Efficiency And Safety. For further insights on this market. request a sample here

North America was the largest region in the pharmacovigilance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us